Daniel Ansari
21 – 30 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Acute pancreatitis–can evidence-based guidelines be transferred to an optimized comprehensive treatment program?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas
- Contribution to journal › Article
-
Mark
Macropinocytosis : the Achilles’ heel of pancreatic cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Organoid technology for personalized pancreatic cancer therapy
- Contribution to journal › Scientific review
- 2020
-
Mark
The Dilemma of Drains after Pancreatoduodenectomy : Still an Issue?
- Contribution to journal › Article
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
- Contribution to journal › Article
-
Mark
Re-resection for incidentally detected gallbladder cancer : Weighing in on the options
- Contribution to journal › Debate/Note/Editorial
-
Mark
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
- Contribution to journal › Scientific review
-
Mark
Blood-based markers for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas–what’s beyond the horizon?
- Contribution to journal › Debate/Note/Editorial
-
Mark
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
- Contribution to journal › Article
